In Brief: FDA Dental Products Panel
This article was originally published in The Gray Sheet
FDA Dental Products Panel: Slated to meet Feb. 27-29 at the Bethesda Marriott Hotel, Maryland. On Feb. 27, the panel will review a premarket approval application for "a bone filling device for periodontal use." On Feb. 28, the panel will vote on a PMA for a "dental laser for hard tissue use" and "discuss the reliability and accuracy of digital subtraction radiography and its use in the clinical design of trials evaluating treatment and/or progression of periodontis." On Feb. 29, the panel, "with representation from the Dental Drug Products Plaque Subcommittee," will discuss "public health issues relevant to a new drug application for a dentifrice "for use in the prevention of caries, plaque, and gingivitis." For more information contact Carolyn Tylenda at 301/443-8879...
You may also be interested in...
The Environmental Working Group and Scientific Analytical Institute say inadequate testing of talc-containing personal-care products is to blame for findings of asbestos in cosmetics, including three of 21 powder-based cosmetics SAI analyzed at EWG’s request. They continue to push for updated testing standards that include electron microscopy as a core component.
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.